Abstract
Meningiomas are the second primary brain tumors. For these, total resection remains the treatment of choice, but for those lesions in which there is partial resection or is not possible by its location, or patient’s desire, there are other options such as stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (SRT). This is a report of Hospital Universitario San Ignacio and Centro Javeriano de Oncologia in 29 patients treated in these institutions with SRS or SRT, both in primary and residual meningiomas, in the period between 2009 and 2012. We report the results after three, six and twelve months monitoring, with good local control.
Black P, Morokoff A, Zauberman J, Claus E, Carroll R. Meningiomas: Science and surgery. Clin Neurosurg. 2007;54:91-9.
Alexioua GA, Gogoub P, Markoulac S, Kyritsis AP. Management of meningiomas. Clin Neurol Neurosurg. 2010;112:177-8.
El Majdoub F, Elawady M, Bührle C et al. μMLC-LINAC radiosurgery for intracranial meningiomas of complex shape. Acta Neurochir (Wien). 2012;154:599-604.
Ossama A. Meningiomas. New York: Raven Press; 1991.
Combs SE, Ganswindt U, Foote RL et al. State-of-the-art treatment alternatives for base of skull meningiomas: Complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniques. Radiat Oncol. 2012;7:226. doi: 10.1186/1748-717X-7-226.
Halperin EC, Perez CA, Brady LW. Principles and practice of radiation oncology. 5th ed. s. l.: Wolters Kluwer; 2008.
Hug EB, DeVries A, Thornton AF, et al. Management of atypical and malignant meningiomas: Role of high-dose, 3Dconformal radiation therapy. J Neuro-Oncol. 2000;48(2):151-60.
Elia AEH, Shih HA, Loeffler JS. Stereotactic radiation treatment for benign meningiomas. Neurosurg Focus. 2007;23(4):E5.
Pollock BE, Stafford SL, Link MJ. Stereotactic radiosurgery of intracranial meningiomas. Neurosurg Clin North Am. 2013;24(4):499-507.
Ding D, Starke RM, Hantzmon J, et al. The role of radiosurgery in the management of WHO Grade II and III intracranial meningiomas. Neurosurg Focus. 2013;35(6):E16.
Adeberg S, Hartmann C, Welzel T, et al. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):859-64. doi: 10.1016/j.ijrobp.2011.08.010. Epub 2011 Dec 2.
Sánchez RA, González A, Rocha A. Reproducibilidad del posicionamiento de pacientes en tratamiento con radioterapia del Centro Javeriano de Oncología. Unv Med. 2011;52(1):44-62
Aghi MK, Carter BS, Cosgrove GR, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009;64:56-60.
Yang SY, Park CK, Park SH, et al. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry. 2008;79:574-80.
Fokas E, Hanzel M, Surber G, et al. Stereotactic radiation therapy for benign meningioma: long-term outcome in 318 patients. Int J Radiat Oncol Biol Phys. 2014;89(3):569-75.
Santacroce A, Walier M, Régis J, et al. Long-term tumor control of benign intracranial meningiomas after radiosurgeryin a series of 4565 patients. Neurosurgery. 2012;70(1):32-9. doi: 10.1227/NEU.0b013e31822d408a.
Stafford SL, Pollock BE, Foote RL, et al. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery. 2001;49(5):1029-37.
Friedman WA, Murad GJ, Bradshaw P, et al. Linear accelerator surgery for meningiomas. J Neurosurg. 2005;103:206-9.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.